Keytruda may let some bladder cancer patients avoid bladder removal
Disease control
Ongoing
This phase 2 trial is testing whether the immunotherapy drug Keytruda (pembrolizumab) can help people with muscle-invasive bladder cancer avoid having their bladder removed. About 46 participants will receive two cycles of Keytruda, then doctors will check if the cancer has compl…
Phase: PHASE2 • Sponsor: Matthew Galsky • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC